Race for approval of first oral GLP-1R drug in obesity intensifies with four in phase III trials: GlobalData Read more
Hims & Hers Health to introduce generic Liraglutide in 2025 amid growing demand for weight-loss medications Read more
Top 20 global biopharma companies report 4.3% growth in market capitalisation in Q2 2024, reveals GlobalData Read more